Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel

American Journal of Health-System Pharmacy

Volumn 61, Issue 23, 2004, Pages 2541-2544

  Dowling, Thomas C ^a   Arjomand, Mahiyar ^b   Lin, Emil T ^c   Allen Jr , Loyd V ^d   McPherson, Mary Lynn ^b,e  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Oklahoma University   (United States)

^e School of Pharmacy   (United States)

Author keywords

Absorption; Antiinflammatory agents; Blood levels; Drugs, availability; Excipients; Gels; Ketoprofen; Lecithin; Pharmacokinetics; Poloxamer 407; Topical preparations; Vehicles

Indexed keywords

DRUG VEHICLE; KETOPROFEN; PHOSPHATIDYLCHOLINE; POLOXAMER; EXCIPIENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG FORMULATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRAVIOLET RADIATION; BIOAVAILABILITY; BLOOD; COMPARATIVE STUDY; SKIN ABSORPTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; EXCIPIENTS; GELS; HUMANS; KETOPROFEN; MALE; PHOSPHATIDYLCHOLINES; POLOXAMER; SKIN ABSORPTION;

EID: 15544384141     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.23.2541     Document Type: Article

References (12)

1. Cabre F, Fernandez MF, Calvo L et al. Analgesic, anti-inflammatory, and antipyretic effects of S(+)-ketoprofen in vivo. J Clin Pharmacol. 1998; 38:3S-10S.
2. Beetge E, du Plessis J, Muller DG et al. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAIDs on their transdermal absorption. Int J Pharm. 2000; 193:261-4.
3. Airaksinen O, Venalainen J, Pietilainen T. Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol. 1993; 31:561-3.
4. Moore RA, Tramer MR, Carroll D et al. Quantitative systematic review of topically applied non-steroidal antiinflammatory drugs. BMJ. 1998; 316: 333-8.
5. D'Arienzo M, Pennisi M, Zanolo G et al. Ketoprofen lysine: ketoprofen serum levels and analgesic activity. Drugs Exp Clin Res. 1984; 12:863-6.
6. Shah AK, Wei G, Lenman RC et al. Percutaneous absorption of ketoprofen from different anatomical sites in man. Pharm Res. 1996; 13(1):168-72.
7. Rolf C, Enstrom B, Beauchard C et al. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology. 1999; 38:564-7.
8. Vincent CM, Laugel C, Marty JP. In vitro topical delivery of non-steroidal antiinflammatory drugs though human skin. Arzneimittelforschung. 1999; 49:509-13.
9. Rhee GJ, Woo JS, Hwang SJ et al. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability. Drug Dev Ind Pharm. 1999; 25:717-26.
10. Willimann H, Walde P, Luisi PL et al. Lecithin organogel as matrix for transdermal transport of drugs. J Pharm Sci. 1992; 81:871-4.
11. Lawrence HP, Paquette DW, Smith PC et al. Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis. J Dent Res. 1998; 77:1904-12.
12. Paquette DW, Lawrence HP, McCombs GB et al. Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. J Clin Periodontol. 2000; 27:558-66.